Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Plos One
|
June 16, 2012
Plakophilin3 loss leads to an increase in PRL3 levels promoting K8 dephosphorylation, which is required for transformation and metastasis
Nileema Khapare, Samrat T Kundu, Lalit Sehgal, et al.
The International Journal of Biochemistry & Cell Biology
|
December 10, 2015
Vimentin-mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cells
Crismita Dmello, Sharada Sawant, Hunain Alam, et al.
Cell Biology International
|
April 13, 2021
Generation of a tissue-specific transgenic model for K8 phosphomutants: A tool to investigate the role of K8 phosphorylation during skin carcinogenesis in vivo
Richa Tiwari, Nirmalya Ganguli, Hunain Alam, et al.
BMC Cancer
|
January 24, 2012
Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma
Hunain Alam, Amruta V Bhate, Prakash Gangadaran, et al.
Molecular Cell
|
June 5, 2018
MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes
Shilpa S Dhar, Dongyu Zhao, Tao Lin, et al.
Journal of Cell Science
|
March 11, 2014
14-3-3γ-Mediated transport of plakoglobin to the cell border is required for the initiation of desmosome assembly in vitro and in vivo
Lalit Sehgal, Amitabha Mukhopadhyay, Anandi Rajan, et al.
Cancer Cell
|
April 4, 2020
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer
Hunain Alam, Ming Tang, Mayinuer Maitituoheti, et al.
The Journal of Clinical Investigation
|
November 9, 2013
KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling
Klaus W Wagner, Hunain Alam, Shilpa S Dhar, et al.
Molecular Cancer Therapeutics
|
December 16, 2021
RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors
Anne Roulston, Michal Zimmermann, Robert Papp, et al.
Cell Reports
|
October 21, 2020
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma
Mayinuer Maitituoheti, Emily Z Keung, Ming Tang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Plos One
|
June 16, 2012
Plakophilin3 loss leads to an increase in PRL3 levels promoting K8 dephosphorylation, which is required for transformation and metastasis
Nileema Khapare, Samrat T Kundu, Lalit Sehgal, et al.
The International Journal of Biochemistry & Cell Biology
|
December 10, 2015
Vimentin-mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cells
Crismita Dmello, Sharada Sawant, Hunain Alam, et al.
Cell Biology International
|
April 13, 2021
Generation of a tissue-specific transgenic model for K8 phosphomutants: A tool to investigate the role of K8 phosphorylation during skin carcinogenesis in vivo
Richa Tiwari, Nirmalya Ganguli, Hunain Alam, et al.
BMC Cancer
|
January 24, 2012
Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma
Hunain Alam, Amruta V Bhate, Prakash Gangadaran, et al.
Molecular Cell
|
June 5, 2018
MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes
Shilpa S Dhar, Dongyu Zhao, Tao Lin, et al.
Journal of Cell Science
|
March 11, 2014
14-3-3γ-Mediated transport of plakoglobin to the cell border is required for the initiation of desmosome assembly in vitro and in vivo
Lalit Sehgal, Amitabha Mukhopadhyay, Anandi Rajan, et al.
Cancer Cell
|
April 4, 2020
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer
Hunain Alam, Ming Tang, Mayinuer Maitituoheti, et al.
The Journal of Clinical Investigation
|
November 9, 2013
KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling
Klaus W Wagner, Hunain Alam, Shilpa S Dhar, et al.
Molecular Cancer Therapeutics
|
December 16, 2021
RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors
Anne Roulston, Michal Zimmermann, Robert Papp, et al.
Cell Reports
|
October 21, 2020
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma
Mayinuer Maitituoheti, Emily Z Keung, Ming Tang, et al.
Page
of 3